Zymeworks terminates ATM agreement with Jefferies; issues 2.715M shares upon warrant exercise at $0.0001/share

Zymeworks Inc.

Terminated Open Market Sale Agreement with Jefferies effective Nov 9, 2022; no shares were sold under it.
Issued 1,375,000 common shares on Oct 25 to a warrant holder upon partial exercise of a warrant.
Issued additional 1,340,000 common shares on Oct 27 to same warrant holder upon exercise of the remaining warrant.
Warrant exercise price was $0.0001 per share; total cash received $271.50 for both exercises.
Warrant shares issued under previously filed S-3 registration statement and prospectus supplement.

item 1.02 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Zymeworks Inc. terminated Open Market Sale Agreement with Jefferies LLC (effective 2022-11-09).

Action: termination
Agreement: atm program
Counterparty: Jefferies LLC
Effective: 2022-11-09

Exact text from the filing

On October 26, 2022, Zymeworks Inc. (the “Company”) notified Jefferies LLC (“Jefferies”) of its decision to terminate the Open Market Sale Agreement SM , dated as of October 21, 2022, (the “Sales Agreement”) between the Company and Jefferies, effective as of November 9, 2022.

View on SEC.gov

Browse all material agreements →

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-272531

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.